Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients.
Murase
Y
Y
Wakasugi
T
T
Yagi
K
K
Mabuchi
H
H
D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism*; D002839:Chromans / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D013997:Time Factors; D017211:Treatment Failure; D000077288:Troglitazone
D015415:Biomarkers; D001786:Blood Glucose; D002839:Chromans; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone